Mangrove Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Mangrove Partners’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-86,770	Closed	-$3.01M	–	48
2014 Q4	$3.01M	Hold	86,770	–	–	0.83%	30
2014 Q3	$3.64M	Hold	86,770	–	–	1.05%	29
2014 Q2	$5.08M	Sell	86,770 -70,000	-45%	-$4.41M	1.68%	26
2014 Q1	$9.88M	Sell	156,770 -41,370	-21%	-$2.74M	3.29%	15
2013 Q4	$11.6M	Buy	198,140 +70,000	+55%	+$3.66M	4.85%	5
2013 Q3	$6.75M	Hold	128,140	–	–	3.37%	10
2013 Q2	$9.87M	Buy	+128,140	New	+$10.5M	4.21%	8

Mangrove Partners's ARNA Position: Q1 2022 in Review

Mangrove Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 145,087 shares — an estimated $13.5M sold.

Mangrove Partners first reported a position in ARNA in Q3 2014 and held it in 3 quarters. The position peaked at $13.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Mangrove Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Mangrove Partners sold 145,087 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $13.5M.
Mangrove Partners first reported a position in Arena Pharmaceuticals Inc in Q3 2014 and held it in 3 quarters.
Mangrove Partners's Arena Pharmaceuticals Inc position peaked at $13.5M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.